FYR Diagnostics
✓ Verified ManufacturerAbout
FYR Diagnostics delivers advanced precision medicine solutions from their Missoula, Montana facility, revolutionizing healthcare through innovative extracellular vesicle analysis. The CLIA-certified company operates cutting-edge molecular diagnostic manufacturing and testing services that extend beyond traditional DNA analysis to provide comprehensive disease insights. Specializing in multi-omic blood analysis, FYR Diagnostics utilizes their proprietary SPARCs technology and AI-powered EV-Omics platform to analyze proteins and RNA within extracellular vesicles. This advanced manufacturing capability enables the production of molecular snapshots that reveal critical disease mechanisms, supporting targeted therapy development and biomarker-driven clinical trials. The company manufactures diagnostic solutions through their innovative EVO platform, which enriches disease-associated extracellular vesicles from blood samples. Their state-of-the-art facility produces comprehensive molecular profiling services that capture both protein and RNA signals, enabling healthcare partners to develop precision diagnostic tools and therapeutic strategies. FYR Diagnostics partners with pharmaceutical companies, research institutions, and healthcare organizations through flexible manufacturing engagement models. Their custom study design capabilities and specialized data outputs support the development of next-generation diagnostic products and personalized medicine applications. Located at 1121 E Broadway Street, the company operates under CLIA certification #27D2190551, ensuring the highest quality standards in their molecular diagnostic manufacturing processes.